Early Access — free while we kick the tires
EdgarHawk

Barlow Jeff D.

Chief Legal Officer

Officer

Latest: CLO selling · May 2026

2 filings analyzed · 1 company · Latest 2026-05-13

Companies

Company Buys Sells Direction
MOLINA HEALTHCARE, INC. MOH 0 2 Net selling

Activity

May 2026
medium
Sell
17,811 shares
$3,314,983
Significance 4/10

Chief Legal Officer Barlow sells ~18k MOH shares, fourth open-market sale in 36 months; stock down sharply from highs.

Jeff Barlow, Molina Healthcare's Chief Legal Officer, sold a substantial stake of approximately 18,000 shares in his fourth open-market sale over the past three years, representing a meaningful reduction in his holdings. The timing is notable: the stock has declined significantly from its 52-week high, though it recovered sharply over the prior quarter, yet Barlow chose to sell into that strength rather than hold. His track record as a seller at this company is mixed — his most recent prior sale was poorly timed on a 30-day horizon as the stock rose, but it proved well-timed over a longer period as shares subsequently fell; two earlier sales are too recent to evaluate. Molina itself remains a profitable, growing company with solid fundamentals, making this a C-suite exit of shares in an operationally sound business rather than a panic exit. The consistent pattern of Barlow reducing his stake over time, without any offsetting open-market purchases, suggests ongoing portfolio management rather than conviction-driven selling, though the scale of his fourth sale warrants attention to whether other insiders are following a similar path.

July 2024
low
Sell
5,340 shares
$1,788,900
Significance 4/10

CLO Barlow sells 5,340 shares of MOH at $335.00 ($1.8M); retains 66,148 shares post-transaction.

Barlow Jeff D., Chief Legal Officer of Molina Healthcare, sold 5,340 shares at $335.00 on 2024-07-29, reducing his holdings by 7.5%. The transaction occurred near the midpoint of the stock's 52-week range ($283.98–$419.53), with the stock having declined 16.4% from its 52-week high and risen 18.0% over the 30 days prior to the sale. Across his full open-market history, Barlow's prior sells exhibited poorly-timed exits, with an average 90-day return of +8.3% after the sales—meaning the stock generally rose after he sold. His two prior trades at Molina Healthcare specifically (both on 2023-08-01) similarly showed positive 90-day returns of +8.4% and +8.2%, with a 0% well-timed rate at the 90-day mark. The company's fundamentals remain solid with revenue of $9,880,000,000.00, net income of $301,000,000.00, annual revenue growth of 6.6%, and a P/E of 19.33, providing no clear signal of operational distress prompting an insider exit.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access